← Open Payments lookup

DELIA PATINO: Open Payments

NPI 1528640331 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$492 in 26 payments from 9 companies in 2025. Trend: 2023 $123 · 2024 $532 · 2025 $492

Food & beverage: $492
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$102
Janssen Pharmaceuticals, Inc2$52
ABBVIE INC.2$49
Alkermes, Inc.2$40
Otsuka America Pharmaceutical, Inc.2$33
Axsome Therapeutics, Inc.2$32
E.R. Squibb & Sons, L.L.C.1$21
Neurocrine BioSciences, Inc.1$15

Products named: UZEDY, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, ARISTADA, Auvelity, COBENFY, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.